Trade Mark Journal No.2026/038 18 September 2026

UK00004438980 1 September 2026 (5)

Image for mark UK00004438980 FOCUS-3
International priority date claimed: 1 June 2026 (United States of America) (99858207)
Class 5
Medicated and pharmaceutical preparations for use in the treatment of ADHD; prescription medicines for the treatment of ADHD.

Axsome Therapeutics, Inc.

Representative: Keltie LLP